Attempts were made to clarify whether laboratory guineapigs may harbour a poliovirus which, in 1911, was described as the cause of a disease called guineapig lameness. By the use of ELISA for antibodies against the poliovirus, Theiler's murine encephalomyelitis virus (TMEV), it was shown that two pet shop guineapigs suffering from lameness had extremely high titres against poliovirus, while healthy guineapigs from the same pet shop were negative. Clearly positive results were also found in 35 out of 152 laboratory guineapig sera. Positive results were found in only two out of six breeding centres, but in three out of three experimental units, all of which purchased guineapigs from one of the seropositive breeding colonies. The diseased guineapigs recovered fully after treatment with vitamins in the drinking water, a treatment used for guineapig lameness by small animal practitioners. A theory that vitamin C deficient guineapigs are, due to an impaired steroid secretion, predisposed to succumbing to infection and develop demyelinating disease similar to that in TMEV infected mice is discussed briefly. Guineapig sera were also tested serologically for other infections. Antibodies against lymphocytic choriomeningitis virus, Clostridium piliforme and Toxoplasma gondii were not found, but one breeding colony was infected with adenovirus, pneumonia virus of mice, reovirus type 3, Sendai virus, parainfluenza (simianl virus type 5 and Encephalitozoon cuniculi. Two other breeding colonies were infected with both reovirus type 3 and E. cuniculi. In all three experimental units infection with adenovirus was observed, and in two of these Sendai virus and E. cuniculi antibodies were also found. The pet shop guineapigs were infected with adenovirus, reovirus type 3 and E. cuniculi. Keywords Guineapigs; Cavia porcellusj virusj poliovirus; enterovirusj encephalomyelitisj guineapig lamenessj TMEV The possible existence and research interference of a guinea pig poliovirus has received little attention in laboratory animal health monitoring. This virus may be the cause of an enzootic disease, guineapig lameness, which in 1911 was described by Romer as a
progressive lameness in the hind part leading to chachexia and death within a period of 1-4 weeks of onset. By transmitting the disease to healthy guineapigs in five passages Romer showed the involvement of a filterable virus similar to human poliomyelitis virus. A sporadic form of the disease in which symptoms of lameness are less dominant is named guineapig pest (Petrie & O'Brien 1910 , de Gasperi & Sangiorgi 1913 , Berge 1924 . In 1926 Cole and Kuttner discussed and rejected the possibility that guineapig lameness was caused by salivary gland virus (guineapig cytomegalovirus). Thereafter the infection received little attention among laboratory animal microbiologists, although guineapig sera may have antibodies against the poliovirus, Theiler's murine encephalomyelitis virus (TMEV) (Parker 1976) .It is not listed in any of the major guidelines for health monitoring guineapigs (Laboratory Animal Breeders Association 1990, Charles River Laboratories 1991, Kraft et al. 1994) . To our knowledge, the disease is still diagnosed occasionally in small animal practice and sometimes treated successfully with ascorbic acid. In one breeding colony of laboratory guineapigs accidentally fed a low vitamin C diet we have a personal report of an outbreak of enzootic lameness, treated successfully with ascorbic acid. Such clinical cases may be due to vitamin C deficit alone, but if there is a poliovirus causing guineapig lameness, guineapigs surviving the disease might have antibodies against TMEV. As development of human poliomyelitis in infected individuals is regulated by several determinants, e.g. nutritional status (Davies et al. 1970) , clinical disease in poliovirus infected guineapigs may be induced by a deficit in vitamin C, which would explain why the disease may be treated successfully with ascorbic acid.
The aim of this work is to investigate whether there is a risk of laboratory guineapigs carrying a poliovirus.
Materials and methods

Diseased animals
Contact was made with a pet shop in which the owner claimed that he experienced occasional lameness and death in his guineapigs. At the first visit to the shop one diseased guineapig and seven guineapigs with no signs of this disease were found. At a later visit one diseased and one healthy guineapig were found. Both diseased individuals were males of approximately 8 weeks of age. One was albino (e/e) with a long-haired coat (probably 1/1), the other had a uniform red coat and a corona on the head (St/+ or St/St). At first examination both were extremely 213 depressed, dehydrated, cachectic with a ruffled coat and pale eyes, and were paretic in the hind part. They were given 10 ml isotonic NaCI and 10 ml isotonic glucose s.c., placed in macrolon type III cages on aspen bedding (Finn Tapvei, SF-73620 Kortteinen), fed with Altromin 3020 guineapig diet (Altromin Denmark, DK-2820 Gentofte) and given drinking water ad libitum. To the 600 ml drinking bottle was added 1000 i.u. vitamin A, 120 i.u. vitamin D3, 0.7 mg thiaminhydrochloride, 0.6 mg riboflavin, 4 mg nicotinamide, 0.4 mg pyridoxinhydrochloride, 1.6 mg dexparithenol and 15 mg ascorbic acid (ABCD-vitamin KVL,Pharmacy of the Royal Veterinary and Agricultural University, DK-1870 Frederiksberg C). Blood samples were taken from one of the diseased guineapigs prior to the treatment; the other was too weak for blood sampling. In both cases the situation was greatly improved the day after the initiation of treatment, and within 2 weeks both animals were healthy with no signs of disease. Four weeks after the first examination their blood, and that of eight healthy guineapigs, were sampled. All samples were taken from the vena saphena lateralis and were tested for antibodies against TMEV and cytomegalovirus as described below.
Monitoring poliovirus antibodies in randomly selected bealtby animals
Sixty-nine guineapig sera were kindly donated by two Danish, two Swedish and two German breeding centres (in this text named BI-B6) supplying laboratory guineapigs for the Scandinavian market. Breeding centre B6 was a minor in-house breeding facility, while breeding centres BI-B5 supplied more than 90% of guineapigs used in Scandinavia.
At breeding centre Bl one of us has experienced personally an outbreak of enzootic lameness, which was treated successfully with ascorbic acid. Eighty-three guineapig sera were kindly donated from one German and two Danish experimental units (in this text named EXI-EX3). All three units purchased guineapigs from BS. All sera were tested for antibodies against poliovirus (TMEV)as described below. Each serum was tested in both a virus-coated well and a well coated with the cell culture only. The optical density (00) value for diagnosis was calculated as ODoverall=ODvirus-c9atedwell-ODnon-virus-coatedwe)I' The mean and the standard deviation of the lowest OD' verallvalues found in 27 samples trom three breeding centres (82, 83 and 84) were used for estimation of a cut-off va1ue as shown in this table (mean=0.0448; 5D=0.0611). The P value describes the highest possible probability of results of that category being covered by the same normal distribution as the results of 82, 83 and 84.
Screening selected sera for other infections
From each breeding centre, experimental unit and the pet shop a proportion of sera was selected randomly and tested for the guineapig infections listed for serological investigation by the FELASA guidelines (Kraft et a1. 1994) .
Serological assays
Monitoring for antibodies against poliovirus (TMEVIstrain GDVII), adenovirus, lymphocytic choriomeningitis virus (LCM), pneumonia virus of mice (PVM), reovirus type 3 (Reo 3), Sendai virus, simian virus type 5 (SV5), C. piliforme and E. cuniculi was carried out by enzyme-linked immunosorbent assay (ELISA). Antigen-coated microtitre plates for all ELISA tests were purchased from Charles River Wiga (D-97633 Sulzfeld). All ELISA tests were run by incubating the plates for 2h at room temperature with test sera diluted 1:100 with 0.1 % phosphatebuffered saline (PBS)-Tween 20 followed by washing 6 times with 0.1 % PBS-Tween 20 with NaCI (15 gil). The plates were then incubated with horseradish peroxidase conjugated rabbit anti-guineapig immunoglobulin diluted 1:2000 IP 141, Dako Ltd, DK-2600 Glostrup) for 2 h at room temperature followed by washing as above. O-phenyldiamine IOPD) (Dako Ltd, DK-2600 Glostrup) was the substrate used and was inactivated by 2N sulphuric acid (Struers KEBO Lab, DK-2620 Albertslund). A similar procedure was run for each serum in a well containing control cell culture only, without antigen. Optical densities (OD) were measured using a 492 nm filter and corrected by measurement using a 690 nm reference filter.
A cut-off value for poliovirus antibodies in guineapigs was calculated according to Table  1 . The cut-off values for the other ELISA tests were calculated by taking the mean plus 3 standard deviations of all negative results obtained from testing guineapigs from known non-infected colonies.
Testing for antibodies against T. gondii and cytomegalovirus was carried out by immunofluorescence assay (IFA). For T. gondii testing 10111 antigen suspension (Testman, S-75009 Uppsalal were placed in each well of a lO-well teflon-coated slide (Struers KEBO Lab, DK-2620 Albertslund), dried and heat fixed. For cytomegalovirus pre-fixed mouse cytomegalovirus slides were used (Harlan, UK, Bicester, UK-OX6 OTP). Test sera were diluted 1:40 with PBS before test. Slides were incubated with test sera for 30 min at room temperature, washed three times with PBS, and stained for 30 min at room temperature with FITC-conjugated rabbit anti-guineapig immunoglobulin (F 233, Dako Ltd, DK-2600 Glostrup) diluted 1:40. After washing three times with PBS, the slides were examined for the presence of fluorescent antigen by the use of an immunofluorescence microscope.
All serological assays included the testing of one positive and one negative control serum per ELISAplate or IFA slide. Except for TMEV, E. cuniculi and T. gondii all positive control sera were guineapig sera supplied by the vendors supplying the antigen. As positive control for TMEV a high reaction mouse serum (Charles River Wiga, D-97633 Sulzfeld) was used. The positive serum for E. cuniculi was a guineapig serum selected in the routine screening of guineapigs in our laboratory. The positive control for T. gondii was a rabbit serum (Testman, S-75009 According to Chebyshev's theorem the probability of the 00 values of the diseased animals being part of the same normal distribution to which the 00 values of the healthy guineapigs belong is *P<0.003, tp < 0.003, tp<0.005.
Uppsalal. All negative controls were of the same animal species as the positive controls, but were all selected during routine screening of laboratory animals in our laboratory. The positive and negative controls were tested by the same procedure as the test sera, except for those produced in animal species other than guineapigs, for which the appropriate antiimmunoglobulin was used.
Statistical method
The OD values of serum from healthy and diseased pet shop guineapigs were assessed 
Results
The results from testing guineapigs from the pet shop for antibodies against polioand cytomegaloviruses are given in Table 2 . By application of Chebyshev's theorem a very significant difference in titre between the two diseased animals and the eight healthy animals was shown. According to Table 1 the results of the two diseased guineapigs were evaluated as '+++', i.e. strongly positive by ELISA to poliovirus, while the titres of at least six of the eight healthy animals were extremely low. No antibodies against cytomegalovirus were found.
Results of testing for antibodies against poliovirus in sera from laboratory guineapigs are given in Table 3 . Thirty-five out of 152 sera tested (21.4%) were clearly positive to poliovirus. Antibodies were found in sera from two of the six breeding centres, while in the sera from the other four breeding centres only very low titres were observed. Antibodies against poliovirus were also found in sera from all three experimental units but titres were much lower than those from the two seropositive breeding centres. Also, there was a clear difference in prevalence between breeding centres and experimental units, the prevalence in both the seropositive breeding centres being more than 50%, while in all three experimental units it was less than 25%.
Results from testing guineapig sera serologically for other infections are given in Table 4 . Antibodies against LCM, C. piliforme and T. gondii were not found. Three breeding colonies were free of antibodies against all infections sought. One breeding colony was infected with adenovirus, PVM, Reo 3, Sendai virus, SV5 and E. cuniculi. Two other breeding colonies were infected with both Reo 3 and E. cuniculi. In all three experimental units infection with adenovirus was observed, and in two of these Sendai virus and E. cuniculi antibodies were also found. The pet shop guineapigs were infected with adenovirus, Reo 3 and E. cuniculi.
Discussion
This study gives a clear indication that guineapigs used for research may harbour a poliovirus. At least 35 out of 152 sera examined had antibodies against murine poliovirus. When applying ELISA to diagnostic microbiology, as in this study, it is normal practice to base cut-off values on the mean and standard deviation of a limited sample size (n) of known negative samples. Normal distribution is the basis for application of Chebyshev's theorem. OD values come closer to describing a normal distribution when n -> CJJ. Therefore, as the sample size of healthy guineapigs from the pet shop was only 10 and that of surely non-infected animals from the randomly examined breeding centres and experimental units was only 27, the calculated P values should be regarded as a rough estimate only. Hence, cut-off values were set high enough for false positives to be unlikely. If cut-off values had been lower a higher prevalence may have resulted.
A correlation between the presence of disease and the presence of antibodies is indicated. Breeding centre B1 has a history of guineapig lameness and more than 50% of their guineapig sera were positive. The seroreactions of the diseased guineapigs from the pet shop clearly indicated that they were or had been infected with an agent antigenically related to poliovirus. One healthy guineapig (No.5) from the pet shop had a rather high titre. This could have been due to maternal antibodies as the guineapig was only five weeks old. One clinically affected animal had antibodies during the disease as well as after recovery. This is similar to humans suffering from poliomyelitis (Jawetz et al. 1980) . There was no indication that the disease was caused by cytomegalovirus.
Our observations indicated that there was a connection between vitamin status and the development of this disease. We were able to treat the two extremely ill guineapigs by adding, among other things, vitamin C to the drinking water, the treatment of choice in small animal practice. Our theory is that the disease is seldom observed in laboratory guineapig colonies because laboratory animal units, in order to avoid vitamin C deficiency, always use fresh guineapig diets and may also add ascorbic acid to the drinking water. In pet shops and private homes diets may be subject to long-term storage resulting in the breakdown of vitamin C, or the guineapigs may not be fed a suitable guineapig diet. This may lead to guinea pig lameness when poliovirus infection occurs in guineapigs already subclinically deficient in vitamin C. In mice infected with TMEV paralysis develops when the virus leaves the grey matter and infects the white matter thereby damaging the upper motor neuron system (Lipton & Dal Canto 1976a) . This is equivalent to the original description of guineapig lameness (Romer 1911) . In mice, this effect may be counteracted by immunosuppression (Lipton & Dal Canto 1976b) . Guineapigs with a vitamin C deficiency may be unable to suppress this terminal effect because they have an impaired steroid secretion, as ascorbic acid is a precursor for the synthesis of steroids. Also 217 heredity may be a determinant of disease. Demyelinating disease caused by TMEV in mice is highly influenced by genetics, e.g. DBA/2 is susceptible, while DBA/1 is resistant lLipton & Dal Canto 1979 , Lipton & Melvold 1984 . We intend to work further on these theories.
The finding of poliovirus antibodies in healthy guineapigs in the three experimental units was to be expected, as all three units purchased animals from an infected breeding centre. As poliovirus is not a persistent infection in healthy animals, prevalences as well as titres were lower. These guineapigs were thought to have eliminated the virus followed by a declining antibody titre. However, the risk of purchasing infected guineapigs is highlighted.
The microbial standard of the laboratory guineapigs investigated was variable. In the experimental units antibodies against adenovirus were found in the vast majority of the sera, and in two units, EX2 and EX3, antibodies against Sendai virus were also found. We know from personal reports that in all three experimental units clinical disease related to adenoviral changes in the lungs had been observed. Two breeding centres, B3 and B6, did not have any serologically detectable infections in their guineapigs, while the other breeding centres produced animals with one or several infections, such as adenovirus, PVM, Reo 3, Sendai virus, SV5 and E. cuniculi. This range is similar to the findings in a survey carried out in 1984 -1988 (Kraft & Meier 1990 , i.e. the quality of guineapigs has not been improved dramatically since then. However, it is worth noting that though some BS guineapigs were infected with poliovirus, BS was free of all viruses cited in the FELASA programme.
The final evidence for the existence will be the isolation of this poliovirus. Future work will involve examination of guineapigs from pet shops and the two infected breeding centres. In the meantime, we find these serological data important enough for this infection to be considered in health monitoring of guineapigs, e.g. in the FELASA guidelines. It might be argued, that this should wait for the isolation of the virus, but PVM, Reo 3 and LCM are all included in the FELASAguidelines, yet have never been isolated from guineapigs although detected serologically and there are no reports of verified clinical disease caused by these organisms (van Hoosier & Robinette 1976, Hsiung et al. 19861 .Antibodies to SV5 in guineapigs, also included in the FELASA guidelines, are not the result of a simian but a guineapig strain (Hsiung 1972) . Our study clearly indicates that the disease called guineapig lameness is likely to be caused by a guineapig poliovirus as described by Romer (1911) , and that 85 years later some laboratory guineapigs still harbour this virus.
